Press release
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market - Global Industry Analysis 2024
Cytomegalovirus (CMV) is a virus that belongs to herpesvirus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be analyzed:-Serologic test
-Polymerase chain reaction (PCR) test
Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/167
CMV diagnosis is very critical in pregnant women and immunocompromised individuals. Enzyme-linked immunoassay test is the most widely used serologic testing for CMV infection in laboratories. Besides, PCR technique is also widely implemented for samples of saliva, and urine. Awareness about the infection is essential as most of the cases go undiagnosed at early stages as the disease is asymptomatic.
Cytomegalovirus infection market: Treatment approach
People diagnosed with high risk of CMV infection may be given anti-viral medications to prevent the disease to get in to active stage. There is no cure available for treating the CMV infection. Ganciclovir, Val ganciclovir, Cidofovir, Valacyclovir and Foscarnet are few major anti-viral medications prescribed. In some cases, CMV immune globulin contains antibodies (proteins) may be prescribed to prevent CMV infection. There are certain products in pipeline which includes Cytovir CMV, Letermovir, CytoTect CP 70, Brincidofovir and ASP0113, commercialization of which is expected to fuel the global CMV infection treatment and diagnosis market growth in the near future.
Vital statistics for the global cytomegalovirus infection treatment and diagnosis market
Besides, diagnosis of new CMV cases would be a propelling factor for global cytomegalovirus infection treatment and diagnosis market. The Public Health Agency of Canada estimates that 40%-100% of the global population have CMV antibody present in their body. Immunocompromised patients (HIV, organ transplant), premature infants, newborns and with congenital CMV are at high risk of developing serious illness with CMV infection.
Request for an in-depth table of contents for this report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/167
According to the Centers for Disease Control and Prevention (CDC), one in every 150 infants are born with congenital cytomegalovirus (CMV) infection in the U.S. However, only one in five infants infected with CMV have long term health problems. Prevailing infection rates and demand for effective treatment therapies would be thrusting the cytomegalovirus infection treatment and diagnosis market growth.
Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/ongoing-insight/cytomegalovirus-infection-treatment-and-diagnosis-market-167
CMV infection treatment and diagnosis market: Regional overview
Early diagnosis practices would drive the global cytomegalovirus infection treatment and diagnosis market in developed regions such as North America and Europe, where accessibility to advanced diagnostic and treatment facilities is high compared to the emerging economies. For market players in the diagnosis and treatment of CMV infection, ensuring accessibility and healthcare investment in emerging nations would be critical to generate better return on investments.
Some of the major players in the global cytomegalovirus infection treatment and diagnosis market are Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market - Global Industry Analysis 2024 here
News-ID: 482489 • Views: …
More Releases from CMI - Research Reports

PoC Platform & Technology Market Research Study for the Period (2017 - 2025)
Point of care (PoC) diagnostic devices are used to obtain diagnostic results while being close to the patient and are commonly used in doctor’s office, hospitals, and in home care settings. These devices are commonly preferred in the home care settings, as they do not require technical expertise and deliver instant feedback on various medical tests. The vast applications of POC platform and technology devices include diagnosis of chronic diseases,…

Low Temperature Sterilization Equipment - Market Driver, Outlook, Key Players by …
Low Temperature Sterilization Equipment Market – Advancing Sterilization Solutions
Low temperature sterilization is an effective means to exercise heat and moisture sensitive surgical instrumentation, general equipment, and implant. Low temperature sterilization is used to sterilize unique devices with complex designs or those made of heat and moisture sensitive materials. This type of equipment usually include polymers on cameras, fiber optics, flexible scopes, certain plastics or recyclable invasive medical instruments made of…

Low Temperature Sterilization Equipment - Market Driver, Outlook, Key Players by …
Low temperature sterilization is one of the most commonly used technique for disinfection and sterilization of equipment that are incapable to withstand high pressures and temperature in conventional sterilization techniques such as autoclave and hot air sterilization. Thus, this technique is considered to ideal for devices such as fiber optics, flexible scopes, laryngoscopes, polymers on camera, and others. The commonly used low temperature Technology type is carried out with the…

Life Cell Imaging - Market Driver, Outlook, Key Players by 2025
The global life cell imaging industry has observed a notable growth over the last few decades due to significant increase in the demand for life cell imaging techniques for the study of cancer, neuroscience and drug discovery. Cellular imaging involves use of techniques that enable the detection and analysis of cellular organelles and macromolecules through light- or electron-based microscopes. Cell imaging is rapidly evolving as new technologies are being introduced…
More Releases for CMV
Cytomegalovirus (CMV) Vaccine Market | Exploring Current Trends and Growth Statu …
Cytomegalovirus (CMV) Vaccine Market Outlook and Investment Analysis
What is the current outlook for the Cytomegalovirus (CMV) vaccine market?
The CMV vaccine market is seeing positive growth due to the increasing prevalence of CMV infections globally, particularly in immunocompromised populations such as organ transplant recipients and HIV patients. Moreover, the growing awareness of CMV's impact on newborns has contributed to the push for preventive vaccines. A few vaccines are in advanced clinical…
Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many…
Global Commercial Cooking Device Market Forecast 2018-2025 CMV Sharper Finish, Q …
Market study on Global Commercial Cooking Device 2018 Research Report presents a professional and complete analysis of Global Commercial Cooking Device Market on the current market situation.
Report provides a general overview of the Commercial Cooking Device industry 2018 including definitions, classifications, Commercial Cooking Device market analysis, a wide range of applications and Commercial Cooking Device industry chain structure. The 2018's report on Commercial Cooking Device industry offers the global…
Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives…
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analy …
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can…
Cytomegalovirus (CMV) Infection Therapeutics Pipeline Analysis, 2017 by P&S Mark …
The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process through different types of designations. The pipeline is…